{"id":25189,"date":"2019-09-12T00:00:00","date_gmt":"2019-09-12T00:00:00","guid":{"rendered":"http:\/\/medgoo.com\/index.php\/2019\/09\/12\/hep-c-viremic-kidneys-increasingly-used-for-transplant\/"},"modified":"2019-09-12T00:00:00","modified_gmt":"2019-09-12T00:00:00","slug":"hep-c-viremic-kidneys-increasingly-used-for-transplant","status":"publish","type":"post","link":"https:\/\/medgoo.com\/index.php\/2019\/09\/12\/hep-c-viremic-kidneys-increasingly-used-for-transplant\/","title":{"rendered":"Hep C-Viremic Kidneys Increasingly Used for Transplant"},"content":{"rendered":"<h3>One-year eGFR similar for HCV-seronegative recipients receiving HCV-viremic, non-HCV-viremic kidneys<\/h3>\n<p><b><\/b><\/p>\n<p><b><\/b><\/p>\n<p>THURSDAY, Sept. 12, 2019 (HealthDay News) &#8212; Hepatitis C virus (HCV)-viremic kidneys are increasingly being used for transplants and seem to have good one-year outcomes, according to a study published online Sept. 12 in the <i>Journal of the American Society of Nephrology<\/i>.<\/p>\n<p>Vishnu S. Potluri, M.D., M.P.H., from the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, and colleagues examined trends in HCV-viremic kidney use between April 1, 2015, and March 31, 2019. Advanced matching methods were used to compare estimated glomerular filtration rate (eGFR) for similar kidneys transplanted into highly-similar kidney recipients.<\/p>\n<p>The researchers found that HCV-seronegative recipients received an increasing proportion of HCV-viremic kidneys over time. Two hundred HCV-viremic kidneys were transplanted into HCV-seronegative recipients during the study period compared with 69 into HCV-seropositive recipients; 105 HCV-viremic kidneys were discarded, with a decrease in the probability of discard over time. During the study period, there was an increase in candidates willing to accept a HCV-seropositive kidney (2,936 to 16,809). When transplanted into HCV-seronegative recipients, predictors of organ quality matched for HCV-viremic kidneys and HCV-non-viremic kidneys, with similar one-year eGFR (66.3 versus 67.1 mL\/min\/1.73 m\u00b2; P = 0.86), in spite of worse kidney donor profile index scores assigned to HCV-viremic kidneys. After transplantation of HCV-viremic kidneys, there was no correlation seen for recipient HCV-serostatus with a clinically meaningful difference in one-year eGFR (66.5 versus 71.1 mL\/min\/1.73 m\u00b2; P = 0.056).<\/p>\n<p>&#8220;These findings provide strong evidence that HCV-viremic kidneys are a valuable resource for transplantation,&#8221; the authors write.<\/p>\n<p>Several authors disclosed financial ties to the pharmaceutical industry.<\/p>\n<p><a href=\"https:\/\/jasn.asnjournals.org\/content\/early\/2019\/09\/12\/ASN.2019050462\" target=\"_new\" rel=\"noopener noreferrer\">Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n<p><a href=\"https:\/\/jasn.asnjournals.org\/content\/early\/2019\/09\/12\/ASN.2019070726\" target=\"_new\" rel=\"noopener noreferrer\">Editorial (subscription or payment may be required)<\/a><\/p>\n<p><i><\/i><\/p>\n<p><i>Copyright \u00a9 2019 <a href=\"https:\/\/www.healthday.com\/\" target=\"_new\" rel=\"noopener noreferrer\">HealthDay<\/a>. All rights reserved.<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>One-year eGFR similar for HCV-seronegative recipients receiving HCV-viremic, non-HCV-viremic kidneys<\/p>\n","protected":false},"author":6,"featured_media":25190,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[11],"class_list":["post-25189","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"_links":{"self":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/25189","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/comments?post=25189"}],"version-history":[{"count":0,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/25189\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media\/25190"}],"wp:attachment":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media?parent=25189"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/categories?post=25189"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/tags?post=25189"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}